von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation

MLA

Harry R. Büller, et al. “Von Willebrand Factor Propeptide‐to‐antigen Ratio in HIV‐infected Pregnancy: Evidence of Endothelial Activation.” Journal of Thrombosis and Haemostasis, vol. 19, Dec. 2021, pp. 3168–76. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a22587d87dceb5c3a7694732e210d714&authtype=sso&custid=ns315887.

APA

Harry R. Büller, Elise Schapkaitz, Elena Libhaber, Barry F. Jacobson, & Muriel Meiring. (2021). von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation. Journal of Thrombosis and Haemostasis, 19, 3168–3176.

Chicago

Harry R. Büller, Elise Schapkaitz, Elena Libhaber, Barry F. Jacobson, and Muriel Meiring. 2021. “Von Willebrand Factor Propeptide‐to‐antigen Ratio in HIV‐infected Pregnancy: Evidence of Endothelial Activation.” Journal of Thrombosis and Haemostasis 19 (December): 3168–76. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a22587d87dceb5c3a7694732e210d714&authtype=sso&custid=ns315887.